{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:40:20Z","timestamp":1774489220636,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.dld.2022.10.024","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T01:43:39Z","timestamp":1668735819000},"page":"595-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Spontaneous reporting of adverse reactions related to proton pump inhibitors"],"prefix":"10.1016","volume":"55","author":[{"given":"Valeria","family":"Dipasquale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cicala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Cutroneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Spina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8827-2091","authenticated-orcid":false,"given":"Claudio","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2022.10.024_bib0001","unstructured":"http:\/\/stats.oecd.org\/Index.aspx?DataSetCode=HEALTH_PHMC: [Accessed on 23 November 2021]."},{"key":"10.1016\/j.dld.2022.10.024_bib0002","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","volume":"14","author":"Scarpignato","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.dld.2022.10.024_bib0003","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.dld.2020.04.020","article-title":"Latest insights into the hot question of proton pump inhibitor safety - a narrative review","volume":"52","author":"Savarino","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2022.10.024_bib0004","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.dld.2020.05.025","article-title":"Addressing long-term PPI safety","volume":"52","author":"Scarpignato","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2022.10.024_bib0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1389200219666171207125351","article-title":"Adverse events of proton pump inhibitors: potential mechanisms","volume":"19","author":"Corsonello","year":"2018","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.dld.2022.10.024_bib0006","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0194599816648298","article-title":"Adverse event reporting for proton pump inhibitor therapy: an overview of systematic reviews","volume":"155","author":"Abramowitz","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.dld.2022.10.024_bib0007","unstructured":"European Medicines Agency (2022). Database of Summary of Product Characteristics (SmPCs). https:\/\/www.ema.europa.eu\/en\/medicines\/human"},{"key":"10.1016\/j.dld.2022.10.024_bib0008","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2146\/ajhp160205","article-title":"National trends in prescription drug expenditures and projections for 2016","volume":"73","author":"Schumock","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.dld.2022.10.024_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12948-019-0104-4","article-title":"PPI adverse drugs reactions: a retrospective study","volume":"17","author":"Casciaro","year":"2019","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.dld.2022.10.024_bib0010","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/jocd.13763","article-title":"Dermatologic adverse reactions to proton-pump inhibitors: a synthetized review","volume":"20","author":"Salloum","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.dld.2022.10.024_bib0011","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.anai.2013.08.022","article-title":"Evaluation and management of hypersensitivity to proton pump inhibitors","volume":"111","author":"Bose","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.dld.2022.10.024_bib0012","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jpeds.2013.05.007","article-title":"Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients","volume":"163","author":"Davidson","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2022.10.024_bib0013","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2125.2000.00262.x","article-title":"The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies","volume":"50","author":"Martin","year":"2000","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 4","key":"10.1016\/j.dld.2022.10.024_bib0014","doi-asserted-by":"crossref","first-page":"S308","DOI":"10.1097\/00005176-200211004-00003","article-title":"Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children","volume":"35","author":"Tolia","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2022.10.024_bib0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.MPG.0000155369.54464.41","article-title":"Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease","volume":"40","author":"Fiedorek","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2022.10.024_bib0016","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/apa.15213","article-title":"The effects of proton pump inhibitors on the microbiome in young children","volume":"109","author":"Levy","year":"2020","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.dld.2022.10.024_bib0017","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.cgh.2009.05.021","article-title":"Nordic GERD Study Group. Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis","volume":"7","author":"Lundell","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.10.024_bib0018","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.2011.626","article-title":"Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial","volume":"305","author":"Galmiche","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2022.10.024_bib0019","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cgh.2012.11.031","article-title":"Oldfield EC 4th Reported side effects and complications of long-term proton pump inhibitor use: dissecting the evidence","volume":"11","author":"Johnson","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.10.024_bib0020","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ejim.2014.10.001","article-title":"Understanding adverse drug reactions in older adults through drug-drug interactions","volume":"25","author":"Marengoni","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.dld.2022.10.024_bib0021","first-page":"A371","article-title":"Effect of omeprazole on the bioavailability of aspirin: a randomized controlled study on healthy volunteers","volume":"116","author":"Anand","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.10.024_bib0022","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjp.0703920","article-title":"HMG-CoA reductase inhibitors and P-glycoprotein modulation","volume":"132","author":"Bogman","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.dld.2022.10.024_bib0023","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s40264-017-0564-8","article-title":"Muscular adverse drug reactions associated with proton pump inhibitors: a disproportionality analysis using the Italian national network of pharmacovigilance database","volume":"40","author":"Capogrosso Sansone","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.dld.2022.10.024_bib0024","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2018.2513","article-title":"Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood","volume":"172","author":"Mitre","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.dld.2022.10.024_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/14740338.2021.1978975","article-title":"Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data","volume":"21","author":"Dipasquale","year":"2022","journal-title":"Expert Opin Drug Saf"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822007800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822007800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:21:23Z","timestamp":1761625283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865822007800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1590865822007800"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2022.10.024","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spontaneous reporting of adverse reactions related to proton pump inhibitors","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2022.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}